Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 SEK | +0.37% | +3.44% | -66.08% |
15/05 | Transcript : Scandion Oncology A/S - Special Call | |
21/03 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
Chart calendar Scandion Oncology A/S
Upcoming events on Scandion Oncology A/S
Past events on Scandion Oncology A/S
06/05/2024 05:30 pm | Annual General Meeting |
28/02/2024 02:30 pm | Q4 2023 Earnings Call |
28/02/2024 01:30 pm | Q4 2023 Earnings Release |
05/02/2024 06:30 pm | R&D Day |
22/11/2023 02:30 pm | Q3 2023 Earnings Call |
22/11/2023 | Q3 2023 Earnings Release |
20/10/2023 | European Society for Medical Oncology Congress |
10/10/2023 | LSX Nordic Congress |
25/08/2023 12:00 pm | Q2 2023 Earnings Release |
23/08/2023 01:30 pm | Q2 2023 Earnings Call |
26/05/2023 01:30 pm | Q1 2023 Earnings Call |
26/05/2023 12:30 pm | Q1 2023 Earnings Release |
26/04/2023 | Annual General Meeting |
22/02/2023 02:30 pm | FY 2022 Earnings Call |
22/02/2023 | FY 2022 Earnings Release Pre-market |
16/11/2022 02:30 pm | Q3 2022 Earnings Call |
16/11/2022 01:00 pm | Q3 2022 Earnings Release |
28/10/2022 02:30 pm | Extraordinary Shareholders Meeting |
25/08/2022 01:30 pm | Interim 2022 Earnings Call |
25/08/2022 | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,30 - | 0,00 0,00 - |
EBITDA Million DKK | Released Forecast Spread | 0,00 | -54,9 -54,0 -1.7% | -79,3 -85,5 7.3% | -44,4 -41,0 -8.26% |
EBIT Million DKK | Released Forecast Spread | 0,00 | -55,0 -54,0 -1.82% | -80,2 -86,0 6.73% | -45,4 -41,0 -10.63% |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 0,00 | -56,8 -54,0 -5.23% | -82,2 -86,8 5.34% | -44,7 -41,0 -9.03% |
Net income Million DKK | Released Forecast Spread | -16,3 | -51,3 -42,0 -22.18% | -76,7 -81,1 5.41% | -39,2 -35,0 -12.01% |
EPS SEK | Released Forecast Spread | -1,13 | -2,28 -1,80 -26.6% | -2,78 -3,14 11.69% | -1,44 -0,31 -370.07% |
Announcement Date | 29/04/21 | 17/02/22 | 22/02/23 | 28/02/24 |
Quarterly results
Fiscal Period | December | 2022 Q1 |
---|---|---|
Net income Million DKK | Released Forecast Spread | -12,9 |
EPS SEK | Released Forecast Spread | -0,56 |
Announcement Date | 19/05/22 |
Past sector events for Scandion Oncology A/S
Today 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Today | BIOCON LIMITED: Q4 2024 Earnings Release |
15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 05:30 pm | IMMUNOME, INC.: Q1 2024 Earnings Release |
14/05/2024 04:30 pm | IMMATICS N.V.: Q1 2024 Earnings Release |
14/05/2024 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
14/05/2024 10:30 am | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCOL Stock
- Calendar Scandion Oncology A/S